Cellectis (CLLS) Misses Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts CLLS Hot Sheet
Join SI Premium – FREE
Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.22 million versus the consensus estimate of $21.71 million.
For earnings history and earnings-related data on Cellectis (CLLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ConAgra Brands (CAG) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY EPS Guidance
- Freightos Q2 transactions and GBV beat internal targets
- BioHarvest receives $1.4M grant from Israel Innovation Authority
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
